Your browser doesn't support javascript.
loading
Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges.
Saini, K S; Svane, I M; Juan, M; Barlesi, F; André, F.
Affiliation
  • Saini KS; Labcorp Drug Development Inc., Princeton, USA.
  • Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Juan M; Department of Immunology, Hospital Clinic, IDIBAPS, Immunotherapy Platform Hospital Sant Joan de Déu, Universidad de Barcelona, Barcelona, Spain.
  • Barlesi F; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
  • André F; Institut Gustave Roussy, INSERM UMR981, Université Paris Saclay, Paris, France. Electronic address: fabrice.andre@gustaveroussy.fr.
Ann Oncol ; 33(1): 6-12, 2022 01.
Article in En | MEDLINE | ID: mdl-34655734
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido